Literature DB >> 21673231

Enhancing mitochondrial respiration suppresses tumor promoter TPA-induced PKM2 expression and cell transformation in skin epidermal JB6 cells.

Jennifer A Wittwer1, Delira Robbins, Fei Wang, Sarah Codarin, Xinggui Shen, Christopher G Kevil, Ting-Ting Huang, Holly Van Remmen, Arlan Richardson, Yunfeng Zhao.   

Abstract

Differentiated cells primarily metabolize glucose for energy via the tricarboxylic acid cycle and oxidative phosphorylation, but cancer cells thrive on a different mechanism to produce energy, characterized as the Warburg effect, which describes the increased dependence on aerobic glycolysis. The M2 isoform of pyruvate kinase (PKM2), which is responsible for catalyzing the final step of aerobic glycolysis, is highly expressed in cancer cells and may contribute to the Warburg effect. However, whether PKM2 plays a contributing role during early cancer development is unclear. In our studies, we have made an attempt to elucidate the effects of varying mitochondrial respiration substrates on skin cell transformation and expression of PKM2. Tumorigenicity in murine skin epidermal JB6 P+ (promotable) cells was measured in a soft agar assay using 12-O-tetradecanoylphorbol-13-acetate (TPA) as a tumor promoter. We observed a significant reduction in cell transformation upon pretreatment with the mitochondrial respiration substrate succinate or malate/pyruvate. We observed that increased expression and activity of PKM2 in TPA-treated JB6 P+ cells and pretreatment with succinate or malate/pyruvate suppressed the effects. In addition, TPA treatment also induced PKM2 whereas PKM1 expression was suppressed in mouse skin epidermal tissues in vivo. In comparison with JB6 P+ cells, the nonpromotable JB6 P- cells showed no increase in PKM2 expression or activity upon TPA treatment. Knockdown of PKM2 using a siRNA approach significantly reduced skin cell transformation. Thus, our results suggest that PKM2 activation could be an early event and play a contributing role in skin tumorigenesis. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21673231      PMCID: PMC4827450          DOI: 10.1158/1940-6207.CAPR-11-0028

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  46 in total

Review 1.  Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA.

Authors:  Mo Chen; Jian Zhang; James L Manley
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters.

Authors:  T Noguchi; K Yamada; H Inoue; T Matsuda; T Tanaka
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

Review 4.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 5.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

6.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion.

Authors:  Jianfeng Liu; Daret K St Clair; Xin Gu; Yunfeng Zhao
Journal:  FEBS Lett       Date:  2008-03-20       Impact factor: 4.124

10.  The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells.

Authors:  E Marchut; M Gumińska; T Kedryna
Journal:  Acta Biochim Pol       Date:  1986       Impact factor: 2.149

View more
  12 in total

1.  Isocitrate dehydrogenase 1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of manganese superoxide dismutase.

Authors:  Delira Robbins; Jennifer A Wittwer; Sarah Codarin; Magdalena L Circu; Tak Yee Aw; Ting-Ting Huang; Holly Van Remmen; Arlan Richardson; David B Wang; Stephan N Witt; Ronald L Klein; Yunfeng Zhao
Journal:  Cancer Sci       Date:  2012-06-07       Impact factor: 6.716

2.  Prolonged overexpression of Wnt10b induces epidermal keratinocyte transformation through activating EGF pathway.

Authors:  Mingxing Lei; Xiangdong Lai; Xiufeng Bai; Weiming Qiu; Tian Yang; Xiaoling Liao; Cheng-Ming Chuong; Li Yang; Xiaohua Lian; Julia Li Zhong
Journal:  Histochem Cell Biol       Date:  2015-05-21       Impact factor: 4.304

3.  UCP2 knockout suppresses mouse skin carcinogenesis.

Authors:  Wenjuan Li; Chunjing Zhang; Kasey Jackson; Xingui Shen; Rong Jin; Guohong Li; Christopher G Kevil; Xin Gu; Runhua Shi; Yunfeng Zhao
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-17

4.  A role for FGF2 in visceral adiposity-associated mammary epithelial transformation.

Authors:  Vanessa Benham; Debrup Chakraborty; Blair Bullard; Jamie J Bernard
Journal:  Adipocyte       Date:  2018-03-21       Impact factor: 4.534

5.  PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.

Authors:  Wenjuan Li; Joan Liu; Yunfeng Zhao
Journal:  Mol Carcinog       Date:  2012-12-19       Impact factor: 4.784

Review 6.  Manganese superoxide dismutase in cancer prevention.

Authors:  Delira Robbins; Yunfeng Zhao
Journal:  Antioxid Redox Signal       Date:  2013-07-18       Impact factor: 8.401

7.  Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation.

Authors:  Wenjuan Li; Chunjing Zhang; Amy Ren; Teena Li; Rong Jin; Guohong Li; Xin Gu; Runhua Shi; Yunfeng Zhao
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

8.  Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.

Authors:  Chung-Ling Lu; Lili Qin; Hsin-Chen Liu; Demet Candas; Ming Fan; Jian Jian Li
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

Review 9.  Role of Redox Status in Development of Glioblastoma.

Authors:  Aleli Salazar-Ramiro; Daniela Ramírez-Ortega; Verónica Pérez de la Cruz; Norma Y Hérnandez-Pedro; Dinora Fabiola González-Esquivel; Julio Sotelo; Benjamín Pineda
Journal:  Front Immunol       Date:  2016-04-26       Impact factor: 7.561

10.  MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.

Authors:  Ran Tang; Chao Yang; Xiang Ma; Younan Wang; Dakui Luo; Chi Huang; Zekuan Xu; Ping Liu; Li Yang
Journal:  Oncotarget       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.